跳至主要内容
临床试验/CTRI/2025/08/093791
CTRI/2025/08/093791尚未招募2 期

A Randomized Open Label Controlled Clinical Study to Compare the Efficacy of Rasanjanadya Aschyotana and Olopatadine 0.1% Eye Drops in the Management of Kaphaja Abhishyanda (Simple Allergic Conjunctivitis)

Institute for Ayurved Studies and Research1 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2025年12月1日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
44
试验地点
1
主要终点
1. Change in scoring pattern of sign and symptoms of Kaphaja Abhishyanda (Simple Allergic Conjunctivitis).

研究概览

简要总结

Kaphaja Abhishayanda is characterized by Ushnaabhinanda (Want of warmth), Guruta (heaviness of lids), Akhshishopha (swelling of eyes), Kandu (itching), Updeha (stickiness in eyes), Atisitata (Excessive coldness), Sravamuhurpichila (recurrent excessive slimy discharge from eye); so, on the basis of signs and symptoms Kaphaja Abhishyanda can be correlated with Simple Allergic Conjunctivitis. Simple Allergic Conjunctivitis, is a type-1 immediate hypersensitivity reaction mediated by IgE and subsequent mast cell activation, following exposure of ocular surface to airborne allergens.Ayurveda offers an alternative and holistic approach to manage such conditions using herbal formulations that aim at correcting the doshic imbalance while providing symptomatic relief. Rasanjanadya Aschyotana, an Ayurvedic eye drop formulation comprising ingredients like Rasanjana, Haridra, and Madhu is described in classical texts for Kaphaja Abhishyanda*.*This study is designed to evaluate and compare the therapeutic efficacy of Rasanjanadya Aschyotana with that of Olopatadine 0.1% eye drops (Dual action antihistamine and mast cell stabilizer) in patients suffering from Kaphaja Abhishyanda (Simple Allergic Conjunctivitis). By employing a randomized open-label controlled clinical trial design, this research aims to generate scientific evidence for the effectiveness of Rasanjanadya Aschyotana, potentially establishing it as a viable, natural alternative to modern pharmacotherapy.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
16.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Age- 16-60 years
  • Patients with sign and symptoms of Kaphaja Abhishyanda (Simple Allergic Conjunctivitis) will be selected irrespective of Sex, Religion and Profession.
  • Patients those are fit for Aschyotana Karma according to Ayurveda text
  • Patient willing to participate and able to provide signed informed consent.

排除标准

  • Age group less than 16 years and more than 60 years.
  • The patient having any systemic illness, like.
  • Diabetes mellitus, Hypertension, Tuberculosis, etc.
  • Patients suffering from other type of Conjunctivitis, Marginal Corneal Ulcer, Dacryocystitis and other ocular manifestations.
  • Patients with alcohol, opioids / drug addiction and using any other systemic drugs which may alter the result of study.
  • Patients having genetic predisposition to allergy.
  • Pregnant and lactating mothers.

结局指标

主要结局

1. Change in scoring pattern of sign and symptoms of Kaphaja Abhishyanda (Simple Allergic Conjunctivitis).

时间窗: 35th day

次要结局

未报告次要终点

研究者

发起方
Institute for Ayurved Studies and Research
申办方类型
Other [Government Ayurvedic College]
责任方
Principal Investigator
主要研究者

Dr Prerna

Institute for Ayurved Studies and Research SKAU Kurukshetra

研究点 (1)

Loading locations...

相似试验